Description Liquent ensures the quick and easy flow of information from one format to another, helping companies make their regulatory filings crystal clear. Its line of Insight-branded software tools, enables pharmaceutical, biotechnology, and other companies to electronically generate and manage complex documents required by government regulatory agencies. The company's services include consulting, implementation, and support. It sells primarily to midsized to large businesses in the life sciences industry. Clients have included Abbott Laboratories and Novartis. Liquent was part of Thomson Scientific, a unit of Canadian information firm Thomson Reuters, until the company was sold to Marlin Equity Partners in January 2010.